Trelegy Ellipta inhalation powder is used among patients over 18 years of age with COPD to control the symptoms. It is often prescribed prophylactically to prevent bronchospasm. The drug helps to ease breathing, remove wheezing and control the conditions caused by asthma.
The inhaler contains vilanterol, fluticasone and umeclidinium. Vilanterol expands the airways. Umeclidinium has anticholinergic properties. Fluticasone has an anti-inflammatory function.
This medicine is not used to treat asthma attack or sudden bronchospasm. It is not a rescue inhaler and it won’t help to suppress an attack that has already begun. For this purpose, there are other inhalers that are lifesaving and fast acting. Ask your doctor to prescribe you a life-saving product.
If you notice that your medication does not work, or if your conditions worsen, then you should contact your doctor as soon as possible.
Dosage and Application Method
Trelegy Ellipta is taken once a day (1 inhalation fluticasone/umeclidinium/vilanterol 100 mcg-62.5 mcg-25 mcg) orally at regular intervals. You should use the medicine, strictly following all the instructions for using the drug and observing the doctor's advice. Only your doctor can adjust the dosage. If you use the drug incorrectly or do not follow the correct dosage, then this can lead to deterioration in your condition.
The leaflet that comes with the medicine contains all the necessary instructions and information about the drug. If you have any questions about using the inhaler, ask your doctor before using it.
After each inhalation, rinse your mouth with water. This will help to prevent infection in the mouth and throat. Spit out the water after rinsing.
Some circumstances (illnesses, surgery, stress) as well as worsening COPD symptoms may require changing the daily dose of the drug.
If the medicine is prescribed to people who need oral corticosteroids, then the transition to Trelegy Ellipta should be gradual after the body is slowly weaned off the corticosteroid.
The higher the dosage of Trelegy Ellipta is the higher is the likelihood of adverse reactions. In no case increase the dosage prescribed by the doctor.
Overdose symptoms may appear in the following conditions: shortness of breath, chest pain, heart palpitations. More than 1 inhalation per day is not recommended.
During the period of use of the drug Trelegy Ellipta, it is not recommended to be near people who are carriers of any infectious illness.
If you are using an inhaler Trelegy Ellipta, then you should not simultaneously use any inhaler that includes components such as formoterol, salmeterol, indacaterol or arformoterol.
Common side effects of Trelegy Ellipta may include the following symptoms: lung infections, joint pain, nausea, flu and cold symptoms, headache, hoarseness, back pain and others.
A serious side effect is an allergy that includes rash, swelling, breathing problems, hives. If you experience an allergy after using the medicine, seek medical attention immediately.
Seek emergency medical attention if you experience the following: pain when urinating, wheezing while breathing, nervousness, fever, shortness of breath, convulsions, choking, extreme tiredness and loss of energy, and nausea.
Before using the Trelegy Ellipta inhaler, be sure to tell your doctor about all the medicines you take, especially if you are use stomach medicines, cold medicines, antifungals, sedatives, atropine, and if you use any other bronchodilators.
- Trelegy vs Budesonide
- Trelegy vs Albuterol
- Trelegy vs Symbicort
- Trelegy vs Ventolin
- Trelegy vs Combivent
- Trelegy vs Xopenex
- Trelegy vs Breo
- Trelegy vs Pulmicort
- Trelegy vs Dulera
- Trelegy vs Alvesco
- Trelegy vs Flovent
- Trelegy vs Formoterol
- Trelegy vs Beclomethasone
- Trelegy vs Salmeterol
- Trelegy vs Vilanterol
- Trelegy vs Mometasone
- Trelegy vs Breztri
Fluticasone Propionate is a preparation with a strong anti-inflammatory effect.
It also blocks the allergic effect of substances like pollen, pet dander, dust mites and mold.
The drug Vilanterol is a medicine widely used among people with COPD and asthma. It belongs to the group of beta-adrenergic agonists and includes the active substance vilanterolum.